Analysis of nucleic acids

US11499181B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11499181-B2
Application numberUS-201816235996-A
CountryUS
Kind codeB2
Filing dateDec 28, 2018
Priority dateFeb 9, 2011
Publication dateNov 15, 2022
Grant dateNov 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Method of haplotype analysis. In an exemplary method, an aqueous phase containing nucleic acid may be partitioned into a plurality of discrete volumes. At least one allele sequence may be amplified in the volumes from each of a first polymorphic locus and a second polymorphic locus that exhibit sequence variation in the nucleic acid. At least one measure of co-amplification of allele sequences from both loci in the same volumes may be determined. A haplotype of the first and second loci may be selected based on the at least one measure of co-amplification.

First claim

Opening claim text (preview).

We claim: 1. A method of haplotype analysis, the method comprising: partitioning an aqueous phase containing nucleic acid into a plurality of discrete volumes; amplifying in the volumes at least one allele sequence from each of a first polymorphic locus and a second polymorphic locus that exhibit sequence variation in the nucleic acid; determining at least one measure of co-amplification of allele sequences from both loci in the same volumes; and selecting a haplotype of the first and second loci based on the at least one measure of co-amplification; and wherein determining at least one measure includes determining a number of volumes that exhibit co-amplification of a particular allele sequence of the first locus and a particular allele sequence of the second locus, and wherein selecting a haplotype is based on the number of volumes. 2. The method of claim 1 , wherein the first and second loci are contained in a target region of the nucleic acid, and wherein the step of partitioning results in an average concentration of less than about five copies of the target region per volume. 3. The method of claim 1 , wherein the step of determining at least one measure includes a step of determining at least one correlation coefficient for allele-specific amplification data of the first locus correlated with allele-specific amplification data of the second locus from the same volumes. 4. The method of claim 1 , wherein the step of determining at least one measure includes a step of determining a first correlation coefficient and a second correlation coefficient for allele-specific amplification data of a first allele sequence and a second allele sequence of the first locus correlated respectively with allele-specific amplification data of the second locus from the same volumes, and wherein the step of selecting a haplotype is based on a step of comparing the first and second correlation coefficients with each other. 5. The method of claim 1 wherein the step of determining a number of volumes includes a step of determining a first number of volumes and a second number of volumes that exhibit respective co-amplification of a first allele sequence or a second allele sequence of the first locus with a particular allele sequence of the second locus, and wherein the step of selecting a haplotype is based on first and second numbers of volumes. 6. The method of claim 1 , wherein the step of partitioning includes a step of forming an emulsion in which the volumes are droplets. 7. A method of haplotype analysis, the method comprising: partitioning an aqueous phase containing nucleic acid into a plurality of discrete volumes; amplifying in the volumes at least one allele sequence from each of a first polymorphic locus and a second polymorphic locus contained in a target region of the nucleic acid; collecting allele-specific amplification data for each of the loci from individual volumes; correlating allele-specific amplification data for the first locus with allele-specific amplification data for the second locus from the same volumes, wherein correlating includes determining a number of volumes exhibiting co-amplification of a particular allele sequence from both loci; and selecting a haplotype of the target region for the first and second loci based on the step of correlating. 8. The method of claim 7 , wherein the step of partitioning includes a step of forming an emulsion, and wherein the step of collecting includes a step of collecting data from individual droplets of the emulsion. 9. The method of claim 8 , wherein the step of forming an emulsion includes a step of passing the aqueous phase through an orifice such that monodisperse droplets of the aqueous phase are generated. 10. The method of claim 7 , wherein the step of partitioning disposes an average of less than about one genome equivalent of the nucleic acid in each volume. 11. The method of claim 7 , wherein the step of partitioning includes a step of forming at least about 1000 volumes. 12. The method of claim 7 , wherein the step of partitioning includes a step of forming droplets that are about 10 to 1000 micrometers in diameter. 13. The method of claim 7 , wherein the step of partitioning includes a step of partitioning an aqueous phase including optically distinguishable fluorescent probes capable of hybridizing specifically to each allele sequence amplified. 14. The method of claim 7 , wherein the step of amplifying includes a step of amplifying a pair of different allele sequences from the first locus, and wherein the step of collecting data includes a step of collecting data that distinguishes amplification of each allele sequence of the pair in individual droplets. 15. The method of claim 7 , wherein the step of correlating includes a step of separately correlating allele-specific amplification data for each allele sequence of the first locus with allele-specific amplification data for the allele sequence of the second locus. 16. The method of claim 7 , wherein the step of selecting a haplotype is based on which allele-specific amplification data for the first locus exhibits a higher correlation with such allele-specific amplification data for the second locus. 17. The method of claim 7 , further comprising a step of applying a threshold to the allele-specific amplification data to convert it to binary form, wherein the step of correlating is performed with the binary form of the data. 18. A method of haplotype analysis, the method comprising: partitioning an aqueous phase including nucleic acid into a plurality of discrete volumes, wherein partitioning includes forming an emulsion, and wherein forming an emulsion includes passing the aqueous phase through an orifice such that monodisperse droplets of the aqueous phase are generated; amplifying in the volumes an allele sequence from each of a first polymorphic locus and a second polymorphic locus in the nucleic acid; collecting allele-specific amplification data for each allele sequence from individual droplets of the emulsion; and selecting a haplotype of the nucleic acid based at least in part on whether the amplification data indicates a negative or a positive correlation for amplification of the allele sequences in the same volumes.

Assignees

Inventors

Classifications

  • involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP] · CPC title

  • C12Q1/6858Primary

    Allele-specific amplification · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • for diseases caused by alterations of genetic material · CPC title

  • Allele specific primer extension · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11499181B2 cover?
Method of haplotype analysis. In an exemplary method, an aqueous phase containing nucleic acid may be partitioned into a plurality of discrete volumes. At least one allele sequence may be amplified in the volumes from each of a first polymorphic locus and a second polymorphic locus that exhibit sequence variation in the nucleic acid. At least one measure of co-amplification of allele sequences …
Who is the assignee on this patent?
Bio Rad Laboratories Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6858. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).